nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—PTGS2—periodontitis	0.965	1	CbGaD
Naproxen—Nabumetone—MPO—periodontitis	0.00413	0.219	CrCbGaD
Naproxen—Indomethacin—PPARA—periodontitis	0.00287	0.152	CrCbGaD
Naproxen—Indomethacin—CXCL8—periodontitis	0.00199	0.105	CrCbGaD
Naproxen—Ketoprofen—CXCL8—periodontitis	0.00159	0.0843	CrCbGaD
Naproxen—Ibuprofen—CXCL8—periodontitis	0.00157	0.0829	CrCbGaD
Naproxen—Nabumetone—PTGS2—periodontitis	0.00155	0.082	CrCbGaD
Naproxen—Carprofen—PTGS2—periodontitis	0.00148	0.0782	CrCbGaD
Naproxen—Suprofen—PTGS2—periodontitis	0.000913	0.0483	CrCbGaD
Naproxen—Fenoprofen—PTGS2—periodontitis	0.000787	0.0416	CrCbGaD
Naproxen—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—periodontitis	0.000589	0.0366	CbGpPWpGaD
Naproxen—Indomethacin—PTGS2—periodontitis	0.000581	0.0307	CrCbGaD
Naproxen—Flurbiprofen—PTGS2—periodontitis	0.000513	0.0272	CrCbGaD
Naproxen—Ketoprofen—PTGS2—periodontitis	0.000465	0.0246	CrCbGaD
Naproxen—Ibuprofen—PTGS2—periodontitis	0.000457	0.0242	CrCbGaD
Naproxen—AKR1C3—Arachidonic acid metabolism—GGT1—periodontitis	0.000457	0.0284	CbGpPWpGaD
Naproxen—PTGS1—Eicosanoid Synthesis—GGT1—periodontitis	0.000358	0.0222	CbGpPWpGaD
Naproxen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	0.000309	0.0192	CbGpPWpGaD
Naproxen—PTGS1—Overview of nanoparticle effects—CRP—periodontitis	0.0003	0.0186	CbGpPWpGaD
Naproxen—PTGS2—Eicosanoid Synthesis—GGT1—periodontitis	0.000284	0.0177	CbGpPWpGaD
Naproxen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—periodontitis	0.000276	0.0171	CbGpPWpGaD
Naproxen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—periodontitis	0.000256	0.0159	CbGpPWpGaD
Naproxen—PTGS2—Overview of nanoparticle effects—CRP—periodontitis	0.000238	0.0148	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—SERPINF2—periodontitis	0.000214	0.0133	CbGpPWpGaD
Naproxen—AKR1C3—Arachidonic acid metabolism—PTGS2—periodontitis	0.000213	0.0132	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—SERPINF2—periodontitis	0.000204	0.0127	CbGpPWpGaD
Naproxen—PTGS1—Overview of nanoparticle effects—PTGS2—periodontitis	0.000201	0.0125	CbGpPWpGaD
Naproxen—PTGS1—Arachidonic acid metabolism—GGT1—periodontitis	0.000199	0.0124	CbGpPWpGaD
Naproxen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—periodontitis	0.000196	0.0122	CbGpPWpGaD
Naproxen—PTGS1—Overview of nanoparticle effects—CXCL8—periodontitis	0.000195	0.0121	CbGpPWpGaD
Naproxen—CYP1A2—Aflatoxin activation and detoxification—GGT1—periodontitis	0.000194	0.012	CbGpPWpGaD
Naproxen—UGT2B7—Phase II conjugation—GGT1—periodontitis	0.000191	0.0119	CbGpPWpGaD
Naproxen—CYP1A2—Estrogen Receptor Pathway—PPARA—periodontitis	0.000188	0.0117	CbGpPWpGaD
Naproxen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	0.000182	0.0113	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—MPO—periodontitis	0.000167	0.0104	CbGpPWpGaD
Naproxen—PTGS1—Eicosanoid Synthesis—PTGS2—periodontitis	0.000167	0.0104	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—MPO—periodontitis	0.000166	0.0103	CbGpPWpGaD
Naproxen—CYP1A2—Melatonin metabolism and effects—ADRB1—periodontitis	0.000159	0.00991	CbGpPWpGaD
Naproxen—PTGS2—Arachidonic acid metabolism—GGT1—periodontitis	0.000158	0.00982	CbGpPWpGaD
Naproxen—UGT1A1—Phase II conjugation—GGT1—periodontitis	0.000155	0.00965	CbGpPWpGaD
Naproxen—PTGS2—Overview of nanoparticle effects—CXCL8—periodontitis	0.000155	0.00961	CbGpPWpGaD
Naproxen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—periodontitis	0.000139	0.00866	CbGpPWpGaD
Naproxen—PTGS2—C-MYB transcription factor network—MPO—periodontitis	0.000138	0.00855	CbGpPWpGaD
Naproxen—PTGS1—Overview of nanoparticle effects—TNF—periodontitis	0.000136	0.00842	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—MPO—periodontitis	0.000135	0.00839	CbGpPWpGaD
Naproxen—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	0.000133	0.00826	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—MPO—periodontitis	0.000133	0.00824	CbGpPWpGaD
Naproxen—CYP2C8—Arachidonic acid metabolism—GGT1—periodontitis	0.000129	0.00799	CbGpPWpGaD
Naproxen—UGT2B7—NRF2 pathway—GGT1—periodontitis	0.000127	0.00792	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—periodontitis	0.000127	0.00788	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.000127	0.00787	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—GGT1—periodontitis	0.000127	0.00787	CbGpPWpGaD
Naproxen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.000121	0.00751	CbGpPWpGaD
Naproxen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—periodontitis	0.000119	0.00737	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.000113	0.00702	CbGpPWpGaD
Naproxen—UGT2B7—Biological oxidations—GGT1—periodontitis	0.000112	0.00695	CbGpPWpGaD
Naproxen—PTGS1—Overview of nanoparticle effects—IL6—periodontitis	0.000109	0.0068	CbGpPWpGaD
Naproxen—PTGS2—Overview of nanoparticle effects—TNF—periodontitis	0.000108	0.00669	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—MPO—periodontitis	0.000107	0.00667	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—FCGR2A—periodontitis	0.000106	0.0066	CbGpPWpGaD
Naproxen—AKR1C3—Disease—SLC52A3—periodontitis	0.000106	0.00659	CbGpPWpGaD
Naproxen—CYP2C9—Arachidonic acid metabolism—GGT1—periodontitis	0.000105	0.0065	CbGpPWpGaD
Naproxen—UGT1A1—NRF2 pathway—GGT1—periodontitis	0.000104	0.00644	CbGpPWpGaD
Naproxen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.000103	0.00642	CbGpPWpGaD
Naproxen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.000102	0.00633	CbGpPWpGaD
Naproxen—UGT2B7—NRF2 pathway—AGER—periodontitis	0.000101	0.0063	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—GGT1—periodontitis	0.000101	0.00625	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—TIMP1—periodontitis	9.91e-05	0.00616	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—SERPINF2—periodontitis	9.49e-05	0.0059	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—periodontitis	9.44e-05	0.00586	CbGpPWpGaD
Naproxen—PTGS1—Arachidonic acid metabolism—PTGS2—periodontitis	9.26e-05	0.00575	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CCR2—periodontitis	9.21e-05	0.00572	CbGpPWpGaD
Naproxen—UGT1A1—Biological oxidations—GGT1—periodontitis	9.09e-05	0.00565	CbGpPWpGaD
Naproxen—CYP1A2—Arachidonic acid metabolism—GGT1—periodontitis	8.94e-05	0.00556	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—SLC52A3—periodontitis	8.88e-05	0.00552	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—CRP—periodontitis	8.79e-05	0.00546	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	8.78e-05	0.00546	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—CRP—periodontitis	8.73e-05	0.00543	CbGpPWpGaD
Naproxen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	8.71e-05	0.00541	CbGpPWpGaD
Naproxen—PTGS2—Overview of nanoparticle effects—IL6—periodontitis	8.69e-05	0.0054	CbGpPWpGaD
Naproxen—UGT1A1—NRF2 pathway—AGER—periodontitis	8.25e-05	0.00512	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL4—periodontitis	8.22e-05	0.00511	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	8.2e-05	0.00509	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—GGT1—periodontitis	8.13e-05	0.00505	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—periodontitis	7.67e-05	0.00476	CbGpPWpGaD
Naproxen—PTGS1—Biological oxidations—GGT1—periodontitis	7.41e-05	0.0046	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—CCL2—periodontitis	7.23e-05	0.00449	CbGpPWpGaD
Naproxen—AKR1C3—Disease—LTF—periodontitis	7.21e-05	0.00448	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—CCL2—periodontitis	7.18e-05	0.00446	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—periodontitis	7.13e-05	0.00443	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—CRP—periodontitis	7.1e-05	0.00441	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—CRP—periodontitis	6.98e-05	0.00433	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL1A—periodontitis	6.6e-05	0.0041	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—GGT1—periodontitis	6.54e-05	0.00406	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL4—periodontitis	6.38e-05	0.00397	CbGpPWpGaD
Naproxen—AKR1C3—Disease—ACP5—periodontitis	6.25e-05	0.00388	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IFNG—periodontitis	6.15e-05	0.00382	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IFNG—periodontitis	6.11e-05	0.00379	CbGpPWpGaD
Naproxen—CYP2C8—Arachidonic acid metabolism—PTGS2—periodontitis	5.98e-05	0.00372	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—PTGS2—periodontitis	5.89e-05	0.00366	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—CCL2—periodontitis	5.84e-05	0.00363	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—SLC52A3—periodontitis	5.83e-05	0.00362	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—CCL2—periodontitis	5.74e-05	0.00357	CbGpPWpGaD
Naproxen—CYP1A2—Phase II conjugation—GGT1—periodontitis	5.69e-05	0.00353	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—CRP—periodontitis	5.64e-05	0.00351	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL3—periodontitis	5.63e-05	0.0035	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL1B—periodontitis	5.48e-05	0.00341	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL1B—periodontitis	5.45e-05	0.00338	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—TNF—periodontitis	5.31e-05	0.0033	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TLR4—periodontitis	5.29e-05	0.00329	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ACP5—periodontitis	5.23e-05	0.00325	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	5.11e-05	0.00317	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—SLC52A3—periodontitis	5.08e-05	0.00316	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—NOS2—periodontitis	5.03e-05	0.00313	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IFNG—periodontitis	4.97e-05	0.00309	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—periodontitis	4.96e-05	0.00308	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SERPINF2—periodontitis	4.89e-05	0.00304	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IFNG—periodontitis	4.88e-05	0.00303	CbGpPWpGaD
Naproxen—CYP2C9—Arachidonic acid metabolism—PTGS2—periodontitis	4.87e-05	0.00303	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—GGT1—periodontitis	4.78e-05	0.00297	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—SLC52A3—periodontitis	4.74e-05	0.00295	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PPARA—periodontitis	4.68e-05	0.00291	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—CCL2—periodontitis	4.64e-05	0.00288	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	4.64e-05	0.00288	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CCL2—periodontitis	4.54e-05	0.00282	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	4.45e-05	0.00276	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL1B—periodontitis	4.43e-05	0.00275	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—TIMP1—periodontitis	4.4e-05	0.00273	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL1B—periodontitis	4.35e-05	0.0027	CbGpPWpGaD
Naproxen—UGT2B7—NRF2 pathway—TGFB1—periodontitis	4.29e-05	0.00266	CbGpPWpGaD
Naproxen—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	4.16e-05	0.00259	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	4.14e-05	0.00257	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VIP—periodontitis	4.07e-05	0.00253	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—TNF—periodontitis	3.98e-05	0.00247	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—TNF—periodontitis	3.95e-05	0.00246	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IFNG—periodontitis	3.95e-05	0.00245	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—GGT1—periodontitis	3.89e-05	0.00242	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—SLC52A3—periodontitis	3.86e-05	0.0024	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IFNG—periodontitis	3.86e-05	0.0024	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—PTGS2—periodontitis	3.78e-05	0.00235	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.74e-05	0.00232	CbGpPWpGaD
Naproxen—PTGS2—Disease—SLC52A3—periodontitis	3.66e-05	0.00228	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCR2—periodontitis	3.63e-05	0.00225	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CXCL8—periodontitis	3.59e-05	0.00223	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL1B—periodontitis	3.52e-05	0.00219	CbGpPWpGaD
Naproxen—UGT1A1—NRF2 pathway—TGFB1—periodontitis	3.49e-05	0.00217	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL1B—periodontitis	3.44e-05	0.00214	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ACP5—periodontitis	3.44e-05	0.00214	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—GGT1—periodontitis	3.33e-05	0.00207	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—MMP9—periodontitis	3.25e-05	0.00202	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TNF—periodontitis	3.22e-05	0.002	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	3.22e-05	0.002	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL6—periodontitis	3.21e-05	0.00199	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL6—periodontitis	3.19e-05	0.00198	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—TNF—periodontitis	3.16e-05	0.00196	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—SLC52A3—periodontitis	3.07e-05	0.00191	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	3.04e-05	0.00189	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	3e-05	0.00187	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	3e-05	0.00187	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ACP5—periodontitis	2.99e-05	0.00186	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—TGFB1—periodontitis	2.95e-05	0.00183	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GGT1—periodontitis	2.91e-05	0.00181	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.84e-05	0.00177	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCR2—periodontitis	2.82e-05	0.00175	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—periodontitis	2.81e-05	0.00175	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ADRB1—periodontitis	2.81e-05	0.00174	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ACP5—periodontitis	2.79e-05	0.00174	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	2.79e-05	0.00173	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.68e-05	0.00166	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TGFB1—periodontitis	2.67e-05	0.00166	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL6—periodontitis	2.6e-05	0.00161	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—periodontitis	2.55e-05	0.00159	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL6—periodontitis	2.55e-05	0.00158	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—PPARA—periodontitis	2.54e-05	0.00158	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—periodontitis	2.5e-05	0.00155	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SLC52A3—periodontitis	2.5e-05	0.00155	CbGpPWpGaD
Naproxen—PTGS2—Disease—LTF—periodontitis	2.49e-05	0.00155	CbGpPWpGaD
Naproxen—ALB—Metabolism—SLC52A3—periodontitis	2.48e-05	0.00154	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—PPARA—periodontitis	2.39e-05	0.00149	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NTRK1—periodontitis	2.3e-05	0.00143	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ACP5—periodontitis	2.28e-05	0.00141	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TIMP1—periodontitis	2.27e-05	0.00141	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.26e-05	0.0014	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS2—periodontitis	2.2e-05	0.00137	CbGpPWpGaD
Naproxen—PTGS2—Disease—ACP5—periodontitis	2.16e-05	0.00134	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP3—periodontitis	2.14e-05	0.00133	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PPARA—periodontitis	2.08e-05	0.00129	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL6—periodontitis	2.06e-05	0.00128	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.04e-05	0.00126	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC52A3—periodontitis	2.03e-05	0.00126	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL6—periodontitis	2.02e-05	0.00125	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GGT1—periodontitis	1.91e-05	0.00119	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—periodontitis	1.84e-05	0.00114	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—GGT1—periodontitis	1.83e-05	0.00114	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	1.82e-05	0.00113	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ACP5—periodontitis	1.81e-05	0.00112	CbGpPWpGaD
Naproxen—AKR1C3—Disease—FGF2—periodontitis	1.79e-05	0.00111	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.74e-05	0.00108	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC52A3—periodontitis	1.74e-05	0.00108	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	1.7e-05	0.00106	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GGT1—periodontitis	1.67e-05	0.00103	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PTGS2—periodontitis	1.62e-05	0.001	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.62e-05	0.001	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GGT1—periodontitis	1.55e-05	0.000966	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	1.5e-05	0.000929	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ACP5—periodontitis	1.47e-05	0.000914	CbGpPWpGaD
Naproxen—ALB—Metabolism—ACP5—periodontitis	1.46e-05	0.000909	CbGpPWpGaD
Naproxen—ALB—Hemostasis—MMP1—periodontitis	1.41e-05	0.000875	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCL2—periodontitis	1.39e-05	0.000863	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PPARA—periodontitis	1.37e-05	0.00085	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PTGS2—periodontitis	1.35e-05	0.000841	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.32e-05	0.000822	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.32e-05	0.000817	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—TGFB1—periodontitis	1.31e-05	0.000814	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.31e-05	0.000812	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	1.28e-05	0.000794	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS2—periodontitis	1.27e-05	0.000789	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GGT1—periodontitis	1.27e-05	0.000787	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—FGF2—periodontitis	1.26e-05	0.00078	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—PPARA—periodontitis	1.24e-05	0.000772	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ACP5—periodontitis	1.2e-05	0.000744	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PPARA—periodontitis	1.19e-05	0.00074	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TGFB1—periodontitis	1.17e-05	0.000726	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PPARA—periodontitis	1.11e-05	0.000691	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL8—periodontitis	1.1e-05	0.000682	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.07e-05	0.000665	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ACP5—periodontitis	1.02e-05	0.000636	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GGT1—periodontitis	1.01e-05	0.000625	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP9—periodontitis	9.93e-06	0.000617	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	9.15e-06	0.000568	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARA—periodontitis	9.07e-06	0.000563	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS2—periodontitis	8.9e-06	0.000553	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—periodontitis	8.81e-06	0.000547	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	8.55e-06	0.000531	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	8.5e-06	0.000528	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TGFB1—periodontitis	8.19e-06	0.000509	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GGT1—periodontitis	8.18e-06	0.000508	CbGpPWpGaD
Naproxen—ALB—Metabolism—GGT1—periodontitis	8.14e-06	0.000506	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—periodontitis	7.75e-06	0.000481	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS2—periodontitis	7.6e-06	0.000472	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—periodontitis	7.23e-06	0.000449	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARA—periodontitis	7.2e-06	0.000447	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	6.96e-06	0.000432	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB1—periodontitis	6.75e-06	0.000419	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GGT1—periodontitis	6.66e-06	0.000414	CbGpPWpGaD
Naproxen—PTGS2—Disease—FGF2—periodontitis	6.2e-06	0.000385	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—periodontitis	6.17e-06	0.000383	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	5.95e-06	0.000369	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—periodontitis	5.9e-06	0.000366	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARA—periodontitis	5.86e-06	0.000364	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARA—periodontitis	5.82e-06	0.000362	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GGT1—periodontitis	5.69e-06	0.000354	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARA—periodontitis	4.77e-06	0.000296	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARA—periodontitis	4.07e-06	0.000253	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFB1—periodontitis	4.04e-06	0.000251	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—periodontitis	3.81e-06	0.000237	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—periodontitis	3.79e-06	0.000235	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—periodontitis	3.1e-06	0.000193	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—periodontitis	3.04e-06	0.000189	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—periodontitis	2.65e-06	0.000165	CbGpPWpGaD
